Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - 3ive Labs; Abbott Vascular; Amgen; AstraZenca; Bayer AG; Boehringer-Ingelheim; Bristol-Myers Squibb; Cardurion; Cytokinetics; Daiichi-Sankyo/Elil Lilly and Company; Edwards Lifesciences; Medtronic; Novartis; ViCardia; Windtree Therapeutics
- Consultant Fee/Honoraria/Speaker's Bureau - Merck/Schering Plough; Verily